NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia & ndash: A brief report from the ORIGIN trialShow others and affiliations
2021 (English)In: Journal of diabetes and its complications, ISSN 1056-8727, E-ISSN 1873-460X, Vol. 35, no 7, article id 107928Article in journal (Refereed) Published
Abstract [en]
In patients with diabetes and cardiovascular or renal comorbidities, circulating levels of the N-terminal fragment of prohormone B-type natriuretic peptide (NT-proBNP) have similar discriminatory ability as multivariate models for prediction of cardiovascular events or death. We validated this finding in patients with dysglycemia not selected for co-existing cardiorenal diseases. (c) 2021 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).
Place, publisher, year, edition, pages
ELSEVIER SCIENCE INC , 2021. Vol. 35, no 7, article id 107928
Keywords [en]
Biomarkers; Cardiovascular disease risk factor; Diabetes mellitus
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:liu:diva-176441DOI: 10.1016/j.jdiacomp.2021.107928ISI: 000655646300009PubMedID: 33906818OAI: oai:DiVA.org:liu-176441DiVA, id: diva2:1565488
Note
Funding Agencies|Sanofi; Swedish Heart Association; Swedish Society of Medicine; Region Ostergotland, Sweden
2021-06-142021-06-142022-05-26